DOMS Industries Limited — Updates, 09-11-2024: Press Release

Revenue for H1 FY25 increased by 18.5% year-on-year (y-o-y) to ₹902.8 Cr, with a notable EBITDA growth of 35.2% y-o-y to ₹172.3 Cr, and net profit after tax (PAT) surged 46.1% y-o-y to ₹108.0 Cr. Key drivers included solid sales of writing pens and adhesives, reflecting strong brand acceptance amidst challenging market conditions. The completion of the acquisition of a 51.8% stake in Uniclan Healthcare enhances the company’s market presence in the baby hygiene segment.

Operationally, capacity expansions have been implemented, including a 20% increase for mathematical instrument boxes and enhancements at existing plants. The retail footprint has expanded from over 1,25,000 to 1,35,000 stores. Looking ahead, the management is optimistic about demand recovery, particularly as the back-to-school season approaches. With ongoing projects and capacity enhancement, DOMS aims to solidify its growth trajectory in both stationery and new product categories. Potential growth appears strong as they leverage their diversified product offering and strengthened market position.